
Sign up to save your podcasts
Or


Vidcast: https://youtu.be/uvPrcomPlKs
The CPSC and Magnussen have recalled Magnussen Nova Series 5-Drawer Chests, Model B1428-10. These tall chests are unstable unless anchored to the wall and they create tip-over and entrapment hazards for children. About 13,200 chests were sold in the US and about 2,520 were sold in Canada. If you have one of these chests, stop using it unless it is anchored properly to the wall. Contact Magnussen at 1-833-748-0210 or email xemail at [email protected] for a refund.
https://www.cpsc.gov/Recalls/2022/Magnussen-Home-Recalls-Nova-Series-5-Drawer-Chests-Due-to-Tip-Over-and-Entrapment-Hazards
#magnussen #novachests #5drawer #tipover #entrapment #recall
Vidcast: https://youtu.be/uvPrcomPlKs
The CPSC and Magnussen have recalled Magnussen Nova Series 5-Drawer Chests, Model B1428-10. These tall chests are unstable unless anchored to the wall and they create tip-over and entrapment hazards for children. About 13,200 chests were sold in the US and about 2,520 were sold in Canada. If you have one of these chests, stop using it unless it is anchored properly to the wall. Contact Magnussen at 1-833-748-0210 or email xemail at [email protected] for a refund.
https://www.cpsc.gov/Recalls/2022/Magnussen-Home-Recalls-Nova-Series-5-Drawer-Chests-Due-to-Tip-Over-and-Entrapment-Hazards
#magnussen #novachests #5drawer #tipover #entrapment #recall
Vidcast: https://youtu.be/QCARNqsurjA
The CPSC and Meridian are recalling Meridian Ottomans. The gold or silver metal band around the base has sharp edges that create a laceration hazard. About 7,800 of these ottomans have been sold nationwide online at Wayfair, Amazon, and Hayneedle, and at 200 stores of their nationwide. If you own one of these ottomans, immediately stop using and contact Meridian Furniture at 1-800-808-0015 or via email at [email protected] to request a prepaid mailing package and shipping label to return the product. In the alternative, provide Meridian with photographic evidence that you have disposed of or destroyed of the product in order to receive a full refund.
https://www.cpsc.gov/Recalls/2022/Meridian-Furniture-Recalls-Ottomans-Due-to-Laceration-Hazard
#meridian #ottomans #laceration #recall
Vidcast: https://youtu.be/QCARNqsurjA
The CPSC and Meridian are recalling Meridian Ottomans. The gold or silver metal band around the base has sharp edges that create a laceration hazard. About 7,800 of these ottomans have been sold nationwide online at Wayfair, Amazon, and Hayneedle, and at 200 stores of their nationwide. If you own one of these ottomans, immediately stop using and contact Meridian Furniture at 1-800-808-0015 or via email at [email protected] to request a prepaid mailing package and shipping label to return the product. In the alternative, provide Meridian with photographic evidence that you have disposed of or destroyed of the product in order to receive a full refund.
https://www.cpsc.gov/Recalls/2022/Meridian-Furniture-Recalls-Ottomans-Due-to-Laceration-Hazard
#meridian #ottomans #laceration #recall
Vidcast: https://youtu.be/pqYPoDLU7FI
The CPSC and Design Within Reach announce the recall of Design Within Reach Arc Collection Furniture. These include the Cafe Chairs, the Lounge Chairs, the Barstools, the Cafe tables, the Coffee tables, and the Bar tables. The surface paint on all of the pieces in this collection fails to meet federal safety standards for lead. Children exposed to these pieces are at risk for lead poisoning. About 200 pieces of this furniture have been sold. If you have one of them, immediately stop using it and contact Design Within Reach at 1-800-338-2107 or via email at [email protected].
https://www.cpsc.gov/Recalls/2022/Design-Within-Reach-Recalls-Arc-Collection-Furniture-Due-to-Violation-of-the-Federal-Lead-Paint-Ban-Recall-Alert
#designwithinreach #arccollection #leadpaint #poisoniong #children #recall
Vidcast: https://youtu.be/pqYPoDLU7FI
The CPSC and Design Within Reach announce the recall of Design Within Reach Arc Collection Furniture. These include the Cafe Chairs, the Lounge Chairs, the Barstools, the Cafe tables, the Coffee tables, and the Bar tables. The surface paint on all of the pieces in this collection fails to meet federal safety standards for lead. Children exposed to these pieces are at risk for lead poisoning. About 200 pieces of this furniture have been sold. If you have one of them, immediately stop using it and contact Design Within Reach at 1-800-338-2107 or via email at [email protected].
https://www.cpsc.gov/Recalls/2022/Design-Within-Reach-Recalls-Arc-Collection-Furniture-Due-to-Violation-of-the-Federal-Lead-Paint-Ban-Recall-Alert
#designwithinreach #arccollection #leadpaint #poisoniong #children #recall
Vidcast: https://youtu.be/mvIBVSrazAI
The Pfizer CoVid vaccine was 90% effective in preventing any CoVid Delta variant infection in fully vaccinated teens 12 to 15 years of age. This from a collaborative study from Israel’s Clalit Institute and the Harvard Medical School that studied 94,354 vaccinated teens and compared their outcomes with an equal number of unvaccinated controls.
The study data shows a gradual development of effective Delta CoVid immunity as the teens received the 2 shots of Pfizer vaccine. Vaccine effectiveness against any Delta CoVid infection was 59% 2-3 weeks after dose 1, 66% 3 to nearly 4 weeks after dose 1, and 90% 1 to 3 weeks after dose 2. The vaccines ability to prevent a symptomatic Delta CoVid infection was 57% 2 to 3 weeks after dose 1, 82% 3 to nearly 4 weeks after dose 1, and 93% one to 3 weeks after dose 2.
This study gives reassuring evidence that 2 doses of at least one of our current CoVid vaccines effectively protects children against the Delta variant of CoVid. This provides an excellent rationale for vaccinating all children.
https://www.nejm.org/doi/full/10.1056/NEJMc2114290
#CoVid #vaccine #children #teens
Vidcast: https://youtu.be/mvIBVSrazAI
The Pfizer CoVid vaccine was 90% effective in preventing any CoVid Delta variant infection in fully vaccinated teens 12 to 15 years of age. This from a collaborative study from Israel’s Clalit Institute and the Harvard Medical School that studied 94,354 vaccinated teens and compared their outcomes with an equal number of unvaccinated controls.
The study data shows a gradual development of effective Delta CoVid immunity as the teens received the 2 shots of Pfizer vaccine. Vaccine effectiveness against any Delta CoVid infection was 59% 2-3 weeks after dose 1, 66% 3 to nearly 4 weeks after dose 1, and 90% 1 to 3 weeks after dose 2. The vaccines ability to prevent a symptomatic Delta CoVid infection was 57% 2 to 3 weeks after dose 1, 82% 3 to nearly 4 weeks after dose 1, and 93% one to 3 weeks after dose 2.
This study gives reassuring evidence that 2 doses of at least one of our current CoVid vaccines effectively protects children against the Delta variant of CoVid. This provides an excellent rationale for vaccinating all children.
https://www.nejm.org/doi/full/10.1056/NEJMc2114290
#CoVid #vaccine #children #teens
Vidcast: https://youtu.be/dVS7dUlRHo8
Those taking the antidepressant drug fluoxetine, branded as Prozac, have a significantly reduced risk of developing progressive age-related macular degeneration, the leading cause of blindness in those over the age of 50. Researchers at the University of Virginia analyzed data from two health insurance databases covering more than 100 million persons after first studying the process leading to AMD and blindness in a mouse model.
The investigators, studying a group of already FDA approved drugs in the lab, showed that fluoxetine uniquely inhibits the inflammatory process leading to retinal degeneration due to its binding with an inflammatory molecule NLRP3-ASC. Armed with this laboratory data, they wanted to see if fluoxetine conferred any clinical benefits for patients with AMD.
Using insurance databases that pinpointed those over the age of 50 with AMD who were taking Prozac and those who were not, analysis revealed that taking fluoxetine significantly slowed the AMD degenerative process. Based on these results, the UVA ophthalmologists are looking forward to a clinical trial of fluoxetine in AMD patients.
https://www.pnas.org/content/118/41/e2102975118
https://www.sciencedaily.com/releases/2021/10/211021120941.htm
#amd #maculardegeneration #blindness #fluoxetine #prozac
Vidcast: https://youtu.be/dVS7dUlRHo8
Those taking the antidepressant drug fluoxetine, branded as Prozac, have a significantly reduced risk of developing progressive age-related macular degeneration, the leading cause of blindness in those over the age of 50. Researchers at the University of Virginia analyzed data from two health insurance databases covering more than 100 million persons after first studying the process leading to AMD and blindness in a mouse model.
The investigators, studying a group of already FDA approved drugs in the lab, showed that fluoxetine uniquely inhibits the inflammatory process leading to retinal degeneration due to its binding with an inflammatory molecule NLRP3-ASC. Armed with this laboratory data, they wanted to see if fluoxetine conferred any clinical benefits for patients with AMD.
Using insurance databases that pinpointed those over the age of 50 with AMD who were taking Prozac and those who were not, analysis revealed that taking fluoxetine significantly slowed the AMD degenerative process. Based on these results, the UVA ophthalmologists are looking forward to a clinical trial of fluoxetine in AMD patients.
https://www.pnas.org/content/118/41/e2102975118
https://www.sciencedaily.com/releases/2021/10/211021120941.htm
#amd #maculardegeneration #blindness #fluoxetine #prozac
From the publisher's feed